Abstract
The normal breast tissue consists of branching ducts, which terminate into the secretory lobular units. The ducts and lobules are lined by two layers of epithelium consisting of the inner secretory epithelial layer and the outer myoepithelial layer. An increase in the number of epithelial cells, three to four cells above the basement membrane, without bridging or distension of the lumina, indicates mild epithelial hyperplasia (Fitzgibbons et al. 1998). Mild epithelial hyperplasia is not associated with increased risk of malignancy (Rogers 1987). This pattern of mild epithelial proliferation is present in most specimens excised for benign and malignant breast tissue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adrales G, Turk P, Wallace T, Bird R, Norton HJ, Greene F (2000) Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by mammotome. Am J Surg 180:313–315
Ali-Fehmi R, Carolin K, Wallis T, Visscher DW (2003) Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol 34:234–239
Arora S, Menes TS, Moung C et al (2008) Atypical ductal hyperplasia at margin of biopsy – is re-excion indicated? Ann Sury Oncol 15:843–847
Arpino G, Allred DC, Mohsin SK et al (2004) Lobular neoplasia on core-needle biopsy – clinical significance. Cancer 101:242–250
Ashikari R, Huvos AG, Snyder RE et al (1974) A clinicopathologic study of atypical lesions of the breast. Cancer 33:310–317
Aubele MM, Cummings MC, Mattis AE et al (2000) Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn Mol Pathol 9:14–19
Azzopardi JG (1979) Papilloma and papillary carcinoma; overdiagnosis of malignancy; underdiagnosis of malignancy. In: Problems in breast pathology. WB Saunders, Philadelphia, pp 150–166; 167–191; 192–239
Baker JL, Hasch F, Blair SL (2012) Atypical ductal hyperplasia at the margin of lumpectomy performed for early stage breast cancer: is there enough evidence to formulate guidelines? (Review article) Int J Surg Oncol:Article IW 297832:5 p. doi:10.1155/2012/297832
Black MM, Chabon AB (1969) In situ carcinoma of the breast. In: Pathology annual. Appleton-Century-Crofts, New York, pp 185–210
Black MM, Barclay THC, Cutler SJ, Hankey BF, Asire AJ (1972) Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer 29:338–343
Bocker W, Bier B, Freytag G et al (1992) An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha smooth muscle actin, vimentin, collagen IV and laminin. Part I: normal breast and benign proliferative lesions. Virchows Arch Pathol Anat Histopathol 421:315–322
Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TJ (1993) Prognostic significance of benign proliferative breast disease. Cancer 71:3896–3907
Boecker W, Buerger H, Schmitz K et al (2001) Ductal epithelial proliferations of the breast: a biological continuum– comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 195:415–421
Boecker W, Moll R, Dervan P et al (2002) Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol 198:458–467
Brem RF, Lechner MC, Jackman RJ et al (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR 190:637–641
Cangiarella J, Guth A, Axelrod D et al (2008) Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy? A report and review of the literature. Arch Pathol Lab Med 132:979–983
Cardenosa G, Eklund GW (1991) Benign papillary neoplasms of the breast: mammographic findings. Radiology 181:751–755
Cardenosa G, Doudna C, Eklund GW (1994) Ductography of the breast: technique and findings. Am J Roentgenol 162:1081–1087
Carter D (1977) Intraduct papillary tumours of the breast. A study of 78 cases. Cancer 39:1689–1692
Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477
Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ (1997) Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 150:297–303
Chuba P, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology and end result data. J Clin Oncol 23:5534–5541
Daniel BL, Gardner RW, Birdwell RL et al (2003) Magnetic resonance of intraductal papilloma of the breast. Magn Reson Imag 21:887–892
Deslauriers N, Lucas S, Michel-Pierre D et al (2012) Breast lesions of uncertain malignant potential: a challenge for surgeons. Cancer Clin Oncol 1:77–87
Di Cristofano C, Mrad K, Zavagila K et al (2005) Papillary lesions of the breast: a molecular progression? Breast Cancer Res Treat 90:71–76
Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151
Eby PR, Ochsner JE, DerMartin WB et al (2009) Frequency and upgrade of atypical ductal hyperplasia diagnosed at sterostatic vacuum – assisted breast biopsy: 9-versus II gauge. Am J Roentgenol 192:229–234
Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL (2001) Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 25:1017–1021
Estabrook A, Asch T, Gump F, Kister SJ, Geller P (1990) Mammographic features of intracystic papillary lesions. Surg Gynecol Obstet 170:113–116
Eusebi V, Magalhaes F, Azzopardi JG (1992) Pleomorphic lobular carcinoma of the breast: an aggressive tumour showing apocrine differentiation. Hum Pathol 22:1232–1239
Fechner RE, Mills SE (1990) Unfolding lobules and ductal hyperplasia. In: Breast pathology, benign proliferations, atypia and in situ carcinomas. ASCP Press, Chicago, pp 89–94
Fisher B, Constantino JP, Wickerham DL et al (1998) Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388
Fitzgibbons PL, Henson DE, Hutter RVP; for the Cancer Committee of the College of American Pathologists (1998) Benign breast changes and the risk for subsequent breast cancer. An update of consensus statement. Arch Pathol Lab Med 122:1053–1055
Francis A, England D, Rowlands D, Bradley S (2002) Breast papilloma: mammogram, ultrasound and MRI appearances. Breast 11:394–397
Frantz VK, Pickren JW, Melcher GW, Auchincloss H Jr (1951) Incidence of chronic cystic disease in so-called “normal” breasts. A study based on 225 postmortem examinations. Cancer 4:762–783
Gadzala DE, Cederbom GJ, Bolton JS et al (1997) Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol 4:283–286
Galimberti V, Monti S, Mastropasqua MG (2013) DCIS and LCIS are confusing outdated terms. They should be abandoned in favour of ductal intraepithelial neoplasia(DIN) and lobular intraepithelial neoplasia (LIN). Breast 22:431–435
Gallagher HS, Martin JE (1969) Early phases in the development of breast cancer. Cancer 24:1170–1178
Gamallo C, Palacios J, Saurez A et al (1993) Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142:987–993
Georgian-Smith D, Lawton TJ (2002) Calcifications of lobular carcinoma in-situ of the breast: radiologic-pathologic correlation. AJR 176:1255–1259
Ghofrani M, Tapia B, Tavassoli FA (2006) Discrepancies in the diagnosis of intraduct proliferative lesions of the breast and its management implications: results of multinational survey. Virclows Arch 449:609–616
Goldstein NS, Lacerna M, Viani E (1998) Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in-situ of the breast. Am J Clin Pathol 110:357–367
Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM (2001) Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res 7:2410–2414
Greene T, Tarter PI, Smith SR, Estabrook A (2006) The significance of surgical margins for patients with atypical hyperplasia. Am J Surg 192:499–501
Haagensen CD (1986a) Solitary intraductal papilloma. In: Haagensen CD (ed) Diseases of the breast, 3rd edn. WB Saunders, Philadelphia, pp 136–175
Haagensen CD (1986b) Multiple intraductal papilloma. In: Haagensen CD (ed) Diseases of the breast, 3rd edn. WB Saunders, Philadelphia, pp 176–191
Haagensen CD, Stout AP, Phillips JS (1951) The papillary neoplasms of the breast. I. Benign intraduct papilloma. Ann Surg 133:18–36
Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769
Hart D (1927) Intracystic papillomatous tumours of the breast. Arch Surg 14:793–835
Helvie MA, Hessler C, Frank TS, Ikeda DM (1991) Atypical hyperplasia of the breast: mammographic appearance and histologic correlation. Radiology 179:759–764
Hendrick JW (1957) Intraductal papilloma of the breast. Surg Gynecol Obstet 105:215–233
Heywang-Köbrunner SH, Dershaw DD, Schreer I (2001) Benign tumors. In: Diagnostic breast imaging. Thieme, Stuttgart, pp 209–235
Hou MF, Tsai KB, Ou-Yangu F et al (2002) Is a one step operation for breast cancer patients presenting nipple discharge without palpable mass feasible. Breast 11:402–407
Jain RK, Mehta R, Dimitrov R et al (2011) Atypical ductal hyperplasia interobserver and intraobserver variability. Mod Pathol 24:917–923
Jones C, Merrett S, Thomas VA, Barker TH, Lakhani SR (2003) Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J Pathol 199:152–156
Kiaer HW, Andersen JA (1977) Focal pregnancy-like changes in the breast. Acta Pathol Microbiol Scand 85:931–941
Kiluk JV, Acs G, Hoover SJ (2007) High risk benign breast lesions: current strategies in management. Cancer Control 14:321–329
Kohr JR, Eby PR, Allison KH et al (2010) Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology 255:723–730
Kramer WM, Rush BF (1973) Mammary duct proliferation in the elderly: a histopathologic study. Cancer 31:130–137
Kraus FT, Neubecker RD (1962) The differential diagnosis of papillary tumours of the breast. Cancer 15:444–455
Lakhani SR, Collins N, Stratton MR, Sloane JP (1995) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48:611–615
Lakhani SR, Slack DN, Hamoudi RA, Colins N, Stratton MR, Sloane PJ (1996) Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 74:129–135
Lakhani S, Audretsch W, Cleton-Jensen AM et al on behalf of Eusoma (2006) The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS) Eur J Cancer 42:2205–2211
Lanyi M (1986) Diagnosis and differential diagnosis of breast calcifications. Springer, Berlin/Heidelberg/New York, p 141
Lechner MC, Jackman RJ, Brem RF et al (1999) Lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous biopsy with surgical correlation: a multi-institutional study (abstr). Radiology 213(P):106
Lewis TJ, Hartmann LC, Maloney SD et al (2006) An analysis of breast cancer risk in women with simple multiple and atypical papillomas. Am J Surg Pathol 30:665–672
Li CI, Malone K, Saltzman BS, Daling JR (2006) Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ 1988–2001. Cancer 106:2104–2112
Liberman L, Cohen MA, Dershaw DD et al (1994) Atypical ductal hyperplasia diagnosed at sterotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR 164:1111–1113
Liberman L, Sama M, Susnik B et al (1999) Lobular carcinoma in-situ at percutaneous breast biopsy: surgical biopsy findings. AJR 173:291–299
Liebens F, Cardinael AS, Schillings AP et al (2008) Current management of lobular in situ neoplasia (update). JBR-BTR 91:166–170
Lininger RA, Park WS, Man Y-G et al (1998) LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. Hum Pathol 29:1113–1118
Lishman SC, Lakhani SR (1999) Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology. Histopathology 35:195–200
London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944
Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM (1998) Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 58:4721–4727
Mao X, Fan C, Zheng H et al (2010) P53 nuclear accumulation and ERα expression in ductal hyperplasia of the breast in a cohort of 215 Chinese women. J Exp Clin Cancer Res 29:112–118
Marshall LM, Hunter DJ, Connolly TL et al (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301
Mastracci TL, Shadeo A, Colby SM et al (2006) Genomic alterations in lobular neoplasia: a micro-array comparative genomic hybridization signature for early neoplastic proliferation in the breast genes. Chromosomes Cancer 45:1007–1017
Mastracci TL, Boulos FI, Andruliz IL, Lam WL (2007) Genomics and pre-malignant lesions: clues to the development of lobular breast cancer. Breast Cancer Res 9:215, http://breast-cancer-research.com/content/9/6/215
McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D and the Cancer and Steroid Hormone Study Group (1992) Histologic types of benign breast disease and the risk for breast cancer. Cancer 69:1408–1414
Menes TS, Kerlikowske K, Shabnam J et al (2009) Rates of atypical ductal hyperplasia have declined with less use of post-menopausal hormone treatment: findings from the breast cancer surveillance consortium. Cancer Epidemiol Biomarkers Prev 18:2822–2828
Moore SW, Pearce J, Ring E (1961) Intraductal papilloma of breast. Surg Gynecol Obstet 112:153–158
Moore MM, William Hargett C III, Hanks JB et al (1994) Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg 225:726–733
Muir R (1941) The evolution of carcinoma of the mama. J Pathol Bacteriol L11(2):155–172
Murad TM, Contesso G, Mouriesse H (1981) Papillary tumours of the large lactiferous ducts. Cancer 48:122–133
NHSBSP (1997) Publication no 3. Pathology reporting in breast cancer screening, 2nd edn. Publishes NHS Cancer Screening Programmes, Sheffield
NHSBSP (2001) Publication no 50. Guidelines for nonoperative diagnostic procedures and reporting in breast cancer screening. Publishes NHS Cancer Screening Programmes, Sheffield
NHSBSP (2005) Publication no 58. Pathology reporting in breast cancer screening, 3rd edn. Publishes NHS Cancer Screening Programmes, Sheffield
Nizri E, Schneebaum S, Klausner JM, Menes TS (2012) Current management of breast borderline lesions – need for further research and guidance. Am J Surg 203:721–725
O’Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC (1998) Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 90:697–703
Ohuchi N, Abe R, Kasai M (1984) Possible cancerous change of intraduct papillomas of the breast. A 3-D reconstruction study of 25 cases. Cancer 54:605–611
O’Malley PF (2010) Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol 23:514–525
Orel SG, Dougherty CS, Reynolds C, Czerniecki BJ, Siegelman ES, Schnall MD (2000) MR imaging in patients with nipple discharge: initial experience. Radiology 216:248–254
Otterbach F, Bànkfalvi A, Bergner S, Decker T, Krech R, Boecker W (2000) Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37:232–240
Page DL (1992) The clinical significance of mammary epithelial hyperplasia. Breast 1:3–7
Page DL, Dupont WD (1992) Indicators of increased breast cancer risk in humans. J Cell Bioch (Supp) 16G:175–182
Page DL, Rogers LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 23:1095–1097
Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH (1978) Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61:1055–1063
Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698–2708
Page DL, Dupont WD, Rogers LW (1988) Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol 19:201–207
Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239
Page DL, Salhany KE, Jensen RA, Dupont WD (1996) Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78:258–266
Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361:125–129
Palli D, Del Turco MR, Simoncini R et al (1991) Benign breast disease and breast cancer: a case–control study in a cohort in Italy. Int J Cancer 47:703–706
Papotti M, Gugliotta P, Ghiringhello B, Bussolati G (1984) Association of breast carcinoma and multiple intraductal papillomas: an histological and immunohistochemical investigation. Histopathology 8:963–975
Port ER, Park A, Bergen PI (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS. Ann Surg Oncol 14:1051–1057
Raju U, Vertes D (1996) Breast papillomas with atypical ductal hyperplasia: a clinicopathological study. Hum Pathol 27:1231–1238
Renshaw AA, Cartagena N, Schenkman RH, Derhagopian RP, Gould EW (2001) Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. Am J Clin Pathol 116:92–96
Rogers LW (1987) Epithelial hyperplasia. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, New York, pp 120–156
Rosai J (1991) Borderline epithelial lesions of the breast. Am J Surg Pathol 15:209–221
Rosen PP (2001) Cystic hypersecretory carcinoma and cystic hypersecretory hyperplasia; lobular carcinoma in situ and atypical lobular hyperplasia. In: Rosen’s breast pathology. Lippincott Williams & Wilkins, Philadelphia, pp 1–22; 527–534; 581–626
Rovno HD, Siegelman ES, Reynolds C, Orel SG, Schnall MD (1999) Solitary intraductal papilloma: findings at MR imaging and MR galactography. Am J Roentgenol 172:151–155
Rubin E, Visscher DW, Alexander RW, Urist MM, Maddox WA (1988) Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer 61:2077–2082
Rubin E, Mazur MT, Urist MM, Maddox WA (1993) Clinical, radiographic, and pathologic correlation of atypical hyperplasia, ductal carcinoma in situ and ductal carcinoma in situ with micro-invasion. Breast 2:21–26
Saddik M, Lai R, Medeiros LJ, McCourty A, Brynes RK (1999) Differential expression of cyclin D1 in breast papillary carcinomas and benign papillomas: an immunohistochemical study. Arch Pathol Lab Med 123:152–156
Schnitt SJ, Jimi A, Kajiro M (1993) The increasing prevalence of benign proliferative breast lesions in Japanese women. Cancer 71:2528–2531
Shaaban AM, O’Neill PA, Davies MPA et al (2003) Declining Estrogen receptor-β expression defines malignant progression of human breast neoplasia. Am J Surg Pathol 27:1502–1512
Shin SJ, Rosen PP (2000) Pregnancy-like (pseudolactational) hyperplasia: a primary diagnosis in mammographically detected lesions of the breast and its relationship to cystic hypersecretory hyperplasia. Am J Surg Pathol 24:1670–1674
Shin SJ, Rosen PP (2002) Excisional biopsy should be performed if lobular carcinoma in-situ is seen on needle core biopsy. Arch Pathol Lab Med 126:697–701
Simmons RM, Osborne MP (1999) The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention. Surg Oncol 8:55–65
Sloane JP and Members of the UK National Coordinating Group for Breast Screening Pathology (1994) Consistency of histopathological reporting of breast lesions detected by screening: findings of the UK National EQA scheme. Eur J Cancer 30A:1414–1419
Sneige N, Lim SC, Whitman GJ et al (2003) Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereo tactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 119:248–253
Sohn V, Keylock J, Arthurs Z et al (2007) Breast papillomas in era of percutaneous needle biopsy. Ann Surg Oncol 14:2979–2984
Tan PH, Aw MY, Yip G et al (2005) Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol 29:625–632
Tavassoli FA (1998) Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140–154
Tavassolli FA (2005) Breast pathology: rationale for adopting the ductal intraepithelial (DIN) classification. Nat Rev Clin Oncol 2:116–117
Tavassoli FA, Devilee P (2003) World Health Organisation classification of tumors: pathology and genetics of breast and female genital organs. I ARC Press, Lyon
Tavassoli FA, Norris HJ (1990) A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518–529
Tavassoli FA, Yeh IT (1987) Lactational and clear cell changes of the breast in nonlactating women. Am J Clin Pathol 87:23–29
Vogelstein B, Fearon ER, Hamilton SR et al (1988) Genetic alterations during colorectal-tumour development. N Engl J Med 319:525–532
Warrick JI, Allred DC (2012) Large, central intraductal papillomas. http://emedicine.medscape.com/article/2020346-overview#showall
Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Int 55:231–273
Wiratkapun C, Keeratitragoon T, Lertsithichai P, Chanplakorn N (2013) Upgrading rate of papillary breast lesions diagnosed by core-needle biopsy. Diagn Interv Radiol. doi:10.5152/dir 2013.017
Wolfe JN (1976) Breast parenchymal patterns and their changes with age. Radiology 121:545–552
Woods ER, Helvie MA, Ikeda DM, Mandell SH, Chapel KL, Adler DD (1992) Solitary breast papilloma: comparison of mammographic, galactographic and pathologic findings. Am J Roentgenol 159:487–491
Xu S, Wei B, Zhang H et al (2008) Evidence of chromosomal alterations in pure usual ductal hyperplasia as breast carcinoma precursor. Oncol Rep 19:1469–1475
Yang WT, Suen M, Metreweli C (1997) Sonographic features of benign papillary neoplasms of the breast: review of 22 patients. J Ultrasound Med 16:161–168
Young OE, Valassiadoy K, Dixon M (2007) A review of current practices in breast conservation surgery in the UK. Ann R Coll Surg Engl 89:118–123
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chinyama, C.N. (2014). Epithelial Proliferative Lesions. In: Benign Breast Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41065-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-41065-9_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41064-2
Online ISBN: 978-3-642-41065-9
eBook Packages: MedicineMedicine (R0)